Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probe

Michael Chen, Kai Wen Cheng, Yi Jou Chen, Chang Hung Wang, Ta Chun Cheng, Kuo Chien Chang, An Pei Kao, Kuo Hsiang Chuang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Intestinal bacterial β-glucuronidase (βG) hydrolyzes glucuronidated metabolites to their toxic form in intestines, resulting in intestinal damage. The development of a method to inhibit βG is thus important but has been limited by the difficulty of directly assessing enzyme activity in live animals. Here, we utilized a fluorescent probe, fluorescein di-β-D-glucuronide (FDGlcU), to non-invasively image the intestinal bacterial βG activity in nude mice. In vitro cell-based assays showed that the detection limit is 104 colony-forming units/well of βG-expressing bacteria, and that 7.81 ng/mL of FDGlcU is enough to generate significant fluorescent signal. In whole-body optical images of nude mice, the maximum fluorescence signal for βG activity in intestines was detected 3 hours after gavage with FDGlcU. Following pretreatment with a bacterial βG inhibitor, the fluorescence signal was significantly reduced in abdomens and excised intestines images. For a 4-day antibiotic treatment to deplete intestinal bacteria, the FDGlcU-based images showed that the βG activity was decreased by 8.5-fold on day 4 and then gradually increased after treatment stopped. The results suggested that FDGlcU-based imaging revealed the in vitro and in vivo activity of intestinal bacterial βG, which would facilitate pharmacodynamic studies of specific bacterial βG inhibitors in animal studies.

Original languageEnglish
Article number3142
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Glucuronidase
Glucuronides
Fluorescein
Fluorescent Dyes
Hydrolysis
Intestines
Nude Mice
Fluorescence
Bacteria
Body Image
Poisons
Abdomen
Limit of Detection
Stem Cells
Anti-Bacterial Agents
Enzymes
In Vitro Techniques

ASJC Scopus subject areas

  • General

Cite this

Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probe. / Chen, Michael; Cheng, Kai Wen; Chen, Yi Jou; Wang, Chang Hung; Cheng, Ta Chun; Chang, Kuo Chien; Kao, An Pei; Chuang, Kuo Hsiang.

In: Scientific Reports, Vol. 7, No. 1, 3142, 01.12.2017.

Research output: Contribution to journalArticle

Chen, Michael ; Cheng, Kai Wen ; Chen, Yi Jou ; Wang, Chang Hung ; Cheng, Ta Chun ; Chang, Kuo Chien ; Kao, An Pei ; Chuang, Kuo Hsiang. / Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probe. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{c725354c05804a4c9abbd6ec8441681a,
title = "Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probe",
abstract = "Intestinal bacterial β-glucuronidase (βG) hydrolyzes glucuronidated metabolites to their toxic form in intestines, resulting in intestinal damage. The development of a method to inhibit βG is thus important but has been limited by the difficulty of directly assessing enzyme activity in live animals. Here, we utilized a fluorescent probe, fluorescein di-β-D-glucuronide (FDGlcU), to non-invasively image the intestinal bacterial βG activity in nude mice. In vitro cell-based assays showed that the detection limit is 104 colony-forming units/well of βG-expressing bacteria, and that 7.81 ng/mL of FDGlcU is enough to generate significant fluorescent signal. In whole-body optical images of nude mice, the maximum fluorescence signal for βG activity in intestines was detected 3 hours after gavage with FDGlcU. Following pretreatment with a bacterial βG inhibitor, the fluorescence signal was significantly reduced in abdomens and excised intestines images. For a 4-day antibiotic treatment to deplete intestinal bacteria, the FDGlcU-based images showed that the βG activity was decreased by 8.5-fold on day 4 and then gradually increased after treatment stopped. The results suggested that FDGlcU-based imaging revealed the in vitro and in vivo activity of intestinal bacterial βG, which would facilitate pharmacodynamic studies of specific bacterial βG inhibitors in animal studies.",
author = "Michael Chen and Cheng, {Kai Wen} and Chen, {Yi Jou} and Wang, {Chang Hung} and Cheng, {Ta Chun} and Chang, {Kuo Chien} and Kao, {An Pei} and Chuang, {Kuo Hsiang}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-03252-4",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probe

AU - Chen, Michael

AU - Cheng, Kai Wen

AU - Chen, Yi Jou

AU - Wang, Chang Hung

AU - Cheng, Ta Chun

AU - Chang, Kuo Chien

AU - Kao, An Pei

AU - Chuang, Kuo Hsiang

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Intestinal bacterial β-glucuronidase (βG) hydrolyzes glucuronidated metabolites to their toxic form in intestines, resulting in intestinal damage. The development of a method to inhibit βG is thus important but has been limited by the difficulty of directly assessing enzyme activity in live animals. Here, we utilized a fluorescent probe, fluorescein di-β-D-glucuronide (FDGlcU), to non-invasively image the intestinal bacterial βG activity in nude mice. In vitro cell-based assays showed that the detection limit is 104 colony-forming units/well of βG-expressing bacteria, and that 7.81 ng/mL of FDGlcU is enough to generate significant fluorescent signal. In whole-body optical images of nude mice, the maximum fluorescence signal for βG activity in intestines was detected 3 hours after gavage with FDGlcU. Following pretreatment with a bacterial βG inhibitor, the fluorescence signal was significantly reduced in abdomens and excised intestines images. For a 4-day antibiotic treatment to deplete intestinal bacteria, the FDGlcU-based images showed that the βG activity was decreased by 8.5-fold on day 4 and then gradually increased after treatment stopped. The results suggested that FDGlcU-based imaging revealed the in vitro and in vivo activity of intestinal bacterial βG, which would facilitate pharmacodynamic studies of specific bacterial βG inhibitors in animal studies.

AB - Intestinal bacterial β-glucuronidase (βG) hydrolyzes glucuronidated metabolites to their toxic form in intestines, resulting in intestinal damage. The development of a method to inhibit βG is thus important but has been limited by the difficulty of directly assessing enzyme activity in live animals. Here, we utilized a fluorescent probe, fluorescein di-β-D-glucuronide (FDGlcU), to non-invasively image the intestinal bacterial βG activity in nude mice. In vitro cell-based assays showed that the detection limit is 104 colony-forming units/well of βG-expressing bacteria, and that 7.81 ng/mL of FDGlcU is enough to generate significant fluorescent signal. In whole-body optical images of nude mice, the maximum fluorescence signal for βG activity in intestines was detected 3 hours after gavage with FDGlcU. Following pretreatment with a bacterial βG inhibitor, the fluorescence signal was significantly reduced in abdomens and excised intestines images. For a 4-day antibiotic treatment to deplete intestinal bacteria, the FDGlcU-based images showed that the βG activity was decreased by 8.5-fold on day 4 and then gradually increased after treatment stopped. The results suggested that FDGlcU-based imaging revealed the in vitro and in vivo activity of intestinal bacterial βG, which would facilitate pharmacodynamic studies of specific bacterial βG inhibitors in animal studies.

UR - http://www.scopus.com/inward/record.url?scp=85020651878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020651878&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-03252-4

DO - 10.1038/s41598-017-03252-4

M3 - Article

AN - SCOPUS:85020651878

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 3142

ER -